Alyeska Investment Group, L.P. Castle Biosciences Inc Transaction History

Alyeska Investment Group, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	BUY	$27.28 - $43.01 $3.65 Million - $5.75 Million	133,774 Added 835.15%	149,792 $5.65 Million
Q4 2019 Feb 14, 2020	SELL	$15.74 - $35.04 $2.62 Million - $5.83 Million	-166,254 Reduced 91.21%	16,018 $550,000
Q3 2019 Nov 14, 2019	BUY	$18.09 - $27.92 $3.3 Million - $5.09 Million	182,272 New	182,272 $3.3 Million

171

25.5M

511K

130K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $733M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.